Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Adial Pharmaceuticals (ADIL)

Adial Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ADIL
DateTimeSourceHeadlineSymbolCompany
29/05/202413:30GlobeNewswire Inc.Adial CEO to Present at the Spring MicroCap Rodeo Conference on June 6thNASDAQ:ADILAdial Pharmaceuticals Inc
15/05/202413:30GlobeNewswire Inc.Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:ADILAdial Pharmaceuticals Inc
14/05/202422:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ADILAdial Pharmaceuticals Inc
22/04/202413:30GlobeNewswire Inc.Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark OfficeNASDAQ:ADILAdial Pharmaceuticals Inc
10/04/202413:30GlobeNewswire Inc.Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use DisorderNASDAQ:ADILAdial Pharmaceuticals Inc
02/04/202413:30GlobeNewswire Inc.Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business UpdateNASDAQ:ADILAdial Pharmaceuticals Inc
02/03/202400:00GlobeNewswire Inc.Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross ProceedsNASDAQ:ADILAdial Pharmaceuticals Inc
28/02/202414:30GlobeNewswire Inc.Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark OfficeNASDAQ:ADILAdial Pharmaceuticals Inc
14/02/202420:22Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ADILAdial Pharmaceuticals Inc
13/02/202414:15GlobeNewswire Inc.Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark OfficeNASDAQ:ADILAdial Pharmaceuticals Inc
25/01/202421:30Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ADILAdial Pharmaceuticals Inc
25/01/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ADILAdial Pharmaceuticals Inc
18/01/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADILAdial Pharmaceuticals Inc
18/01/202413:30GlobeNewswire Inc.Adial Announces Appointment of Tony Goodman as Chief Operating OfficerNASDAQ:ADILAdial Pharmaceuticals Inc
16/01/202421:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADILAdial Pharmaceuticals Inc
12/01/202421:51Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ADILAdial Pharmaceuticals Inc
20/12/202314:00GlobeNewswire Inc.Adial Pharmaceuticals Receives Final Reimbursement Payment from AdovateNASDAQ:ADILAdial Pharmaceuticals Inc
12/12/202321:36Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ADILAdial Pharmaceuticals Inc
08/12/202316:08Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ADILAdial Pharmaceuticals Inc
29/11/202321:47Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADILAdial Pharmaceuticals Inc
29/11/202321:05GlobeNewswire Inc.Adial Pharmaceuticals Regains Compliance with Nasdaq Listing RequirementNASDAQ:ADILAdial Pharmaceuticals Inc
28/11/202321:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADILAdial Pharmaceuticals Inc
24/11/202314:24Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ADILAdial Pharmaceuticals Inc
20/11/202312:46Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ADILAdial Pharmaceuticals Inc
20/11/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ADILAdial Pharmaceuticals Inc
14/11/202322:02GlobeNewswire Inc.Adial Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ADILAdial Pharmaceuticals Inc
08/11/202321:05Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ADILAdial Pharmaceuticals Inc
06/11/202311:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADILAdial Pharmaceuticals Inc
31/10/202312:30GlobeNewswire Inc.Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss “New Aspects in Substance Use Treatment” at The Annual International Society of Addiction Medicine ConferenceNASDAQ:ADILAdial Pharmaceuticals Inc
30/10/202321:24Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:ADILAdial Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ADIL

Your Recent History